CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.

Trembley JH, Kren BT, Abedin MJ, Vogel RI, Cannon CM, Unger GM, Ahmed K

Open source

DOI
10.3390/ph10010025
Published
2017 Feb 21
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph10010025,
  title = {CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.},
  author = {Trembley JH and Kren BT and Abedin MJ and Vogel RI and Cannon CM and Unger GM and Ahmed K},
  year = {2017},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph10010025},
  url = {https://doi.org/10.3390/ph10010025}
}

RIS

TY  - JOUR
TI  - CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.
AU  - Trembley JH
AU  - Kren BT
AU  - Abedin MJ
AU  - Vogel RI
AU  - Cannon CM
AU  - Unger GM
AU  - Ahmed K
PY  - 2017
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph10010025
UR  - https://doi.org/10.3390/ph10010025
ER  - 

APA

JH, T., BT, K., MJ, A., RI, V., CM, C., GM, U., & K, A. (2017). CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph10010025

Source records